Pfizer agrees to revise COVID vaccine contract with EU: Reports Reuters Mar 15, 2023 Under the revised terms, Pfizer is asking for payment for doses ordered that will never be manufactured
GlobalData upgrades Pfizer’s COVID-19 vaccine sales forecast to $37 bn in 2022 EP News Bureau Feb 23, 2023 In 2023, Comirnaty is expected to have an even better year, with sales forecasts up by 16 per cent
BioNTech sees UK trials on cancer vaccines starting this year: Ugur Sahin Reuters Feb 20, 2023 The company wants these therapies, which are based on mRNA technology similar to the one that underpins its COVID-19 vaccine, to…
US govt to procure 1.5 million more doses of Novavax COVID-19 vaccine EP News Bureau Feb 14, 2023 The protein-based vaccine was expected to convince those sceptical of the new mRNA-based vaccines against the virus from rivals…
Health minister unveils India’s first intra-nasal COVID vaccine Press Information Bureau Jan 27, 2023 iNNCOVACC is the world’s first intra-nasal COVID-19 vaccine to receive approval for the primary two-dose schedule, and as a…
First made-in-India intra-nasal COVID vaccine to be launched on R-Day IANS Jan 23, 2023 The nasal vaccine can be taken after six months of the second dose
Sen Sanders asks Moderna not to hike COVID vaccine price Reuters Jan 12, 2023 Sanders said in his letter that raising prices would be particularly egregious after the US government provided around $1.7…
COVID-19: Covovax to get approval as booster in 10-15 days: Adar Poonawalla PTI Jan 11, 2023 He said everyone was looking at India, not just in terms of healthcare, but because the country managed to take care of a huge and…
Novavax’s CEO Stanley Erck to retire this month Reuters Jan 11, 2023 Erck, who has been at the helm of the company since 2011, was responsible for bringing Novavax's COVID vaccine, its first…
Vaccination and boosters reduce transmission: Study PTI Jan 3, 2023 The study demonstrates the benefits of vaccination and boosting, even in settings where many people are still getting infected, in…